Search

Your search keyword '"Drugs -- Laws, regulations and rules -- Intellectual property"' showing total 25 results
Start Over Descriptor "Drugs -- Laws, regulations and rules -- Intellectual property"
25 results on '"Drugs -- Laws, regulations and rules -- Intellectual property"'

2. The Patent Linkage System For Allopathic Medicines In Mexico

Subjects
Drugs -- Laws, regulations and rules -- Intellectual property, Patent infringement -- Laws, regulations and rules, Government regulation, Business, international
Abstract

The decree published in the Official Gazette of the Federation on Sept. 19, 2003, added section IV of article 167 and article 167 bis of the Health Supplies Regulation were [...]

Published
2024

3. Mexico's Patent Linkage System And Allopathic Medicines

Subjects
Drugs -- Laws, regulations and rules -- Intellectual property, Medical law, Patent infringement -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Over 20 years ago, derived from the innumerable and uncontainable violations of pharmaceutical patents and for publicity purposes of the patents that protect allopathic medicines, on 19 September 2003, the [...]

Published
2023

4. TAHIR AMIN TO SPEAK ABOUT UNEQUAL ACCESS TO MEDICATIONS AND THE GLOBAL FALLOUT FROM INTELLECTUAL PROPERTY WARS: OCTOBER 18 TALK IN DOWNTOWN SANTA CRUZ

Subjects
Intellectual property -- Laws, regulations and rules, Drugs -- Laws, regulations and rules -- Intellectual property, Vaccines -- Laws, regulations and rules -- Intellectual property, Intellectual property law, Government regulation, Intellectual property, News, opinion and commentary, University of California, Santa Cruz -- Intellectual property
Abstract

SANTA CRUZ, Calif. -- The following information was released by the University of California - Santa Cruz: By Dan White An expert on intellectual property law, Tahir Amin is a [...]

Published
2022

5. Australia's position on medicines policy in international forums: intellectual property protection and public health

Author

Legge, David G., Gleeson, Deborah H., Lofgren, Hans, and Townsend, Belinda

Subjects
Administrative agencies -- Health policy, Intellectual property -- Laws, regulations and rules, Drugs -- Laws, regulations and rules -- Intellectual property, Public health -- Laws, regulations and rules, Government regulation, Intellectual property, Economics, Political science, Regional focus/area studies
Abstract

Universal access to affordable medicines, which are safe, efficacious and of high quality, and which are appropriately used, depends on national legislation that is in turn constrained by a range [...]

Published
2014

6. The Federal Court Of Appeal Clarifies The 'Obvious To Try' Test

Author

Halwani, Sana

Subjects
Patent licenses -- Cases, Drugs -- Laws, regulations and rules -- Intellectual property, Company legal issue, Government regulation, Business, international
Abstract

The Federal Court of Appeal ('FCA') has clarified the extent of flexibility afforded when undertaking the 'Obvious to Try' test in Amgen v Pfizer, 2020 FCA 188. Although it ultimately [...]

Published
2020

7. Russia could ignore patent rights to produce medicines during epidemics, emergencies - govt bill

Subjects
Russia. State Duma -- Laws, regulations and rules -- International economic relations, Epidemics -- Russia -- Laws, regulations and rules, Drugs -- Laws, regulations and rules -- Intellectual property, Amendments (Parliamentary practice) -- Laws, regulations and rules, International trade -- Laws, regulations and rules, Government securities -- Laws, regulations and rules -- Intellectual property, Patent law, Databases, Inventions, Legislative bills, Government regulation, International trade, Business, Business, international, World Trade Organization -- Intellectual property
Abstract

Russia could ignore patent rights to produce medicines during epidemics, emergencies - govt bill MOSCOW. March 3 (Interfax) - The Russian government has introduced a bill to the State Duma [...]

Published
2020

8. Patents on drugs: manufacturing scarcity or advancing health?

Author

Loft, Bebe and Heywood, Mark

Subjects
Drugs -- Laws, regulations and rules -- Intellectual property, AIDS treatment -- Laws, regulations and rules, Patents (International law) -- Laws, regulations and rules, Government regulation, Agreement on Trade-Related Aspects of Intellectual Property Rights
Abstract

Respect for and promotion of the human rights of people with HIV/AIDS is now an entrenched component of the global response to HIV. However, as the global HIV epidemic has [...]

Published
2002

9. Reports from University of New South Wales Describe Recent Advances in Drug Policy (Making legitimacy: Drug user representation in United Nations drug policy settings)

Subjects
Drugs -- Laws, regulations and rules -- Intellectual property, Patent law, Government regulation, Health, Law, University of New South Wales -- Intellectual property, United Nations -- Intellectual property
Abstract

2020 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Law Weekly -- Investigators discuss new findings in Legal Issues - Drug Policy. According to news [...]

Published
2020

10. Research from University of Bordeaux Reveals New Findings on Drug Policy (Road traffic crash characteristics of drivers who take prescription medicines that carry a risk to driving)

Subjects
Drugs -- Laws, regulations and rules -- Intellectual property, Motor vehicle drivers -- Laws, regulations and rules, Prescriptions (Drugs) -- Laws, regulations and rules -- Intellectual property, Patent law, Government regulation, Health, Law
Abstract

2020 SEP 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Law Weekly -- Current study results on Legal Issues - Drug Policy have been published. According [...]

Published
2020

11. A war over drugs and patents; Drugs, patents and AIDS

Subjects
South Africa -- Laws, regulations and rules, Patent law -- Interpretation and construction, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Laws, regulations and rules -- Intellectual property, Business, Economics, Business, international, Government regulation, Intellectual property, Interpretation and construction, Laws, regulations and rules
Abstract

WHEN it comes to disease, rich countries are quick to share their wealth. For centuries, tuberculosis, measles and other ailments made inroads into much of the poor world, courtesy of [...]

Published
2001

12. Access to important new medicines

Author

Edmonds, Peter, Glynn, Dermot, and Oglialoro, Claudia

Subjects
European Union -- Laws, regulations and rules -- Intellectual property, European Union. European Medicines Agency -- Laws, regulations and rules -- Intellectual property, Patent law -- Interpretation and construction, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Intellectual property, Business, Business, international, Government regulation, Intellectual property, Interpretation and construction, Laws, regulations and rules
Abstract

There are often long delays in the time taken after the approval of new medicines to their being used by patients in different EU member states. This article sets out [...]

Published
2000

13. Stricter Standing For Inter Partes Review?

Author

Brinckerhoff, Courtenay

Subjects
United States. Patent and Trademark Office -- Laws, regulations and rules, Drugs -- Laws, regulations and rules -- Intellectual property, Intellectual property law -- Interpretation and construction, Pharmaceutical industry -- Intellectual property -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Neither the statutes nor the regulations governing Inter Partes Review (IPR) require the party challenging the patent to have been charged with infringement, or even to establish any interest in [...]

Published
2015

14. MSF URGES PRIME MINISTER MODI TO RESIS US POLITICAL PRESSURE TO RESTRICT GLOBAL ACCESS TO MEDICINES

Subjects
Prime ministers -- Laws, regulations and rules, Intellectual property -- Laws, regulations and rules, Drugs -- Laws, regulations and rules -- Intellectual property, Government regulation, Intellectual property, News, opinion and commentary, Doctors Without Borders -- Intellectual property
Abstract

NEW DELHI/NEW YORK -- The following information was released by Doctors Without Borders/Medecins Sans Frontieres (MSF): As Indian prime minister Narendra Modi makes his first official visit to the United [...]

Published
2014

15. Sanofi wins new United States patent for Plavix

Subjects
Government regulation, Sanofi Synthelabo -- Intellectual property, United States. Food and Drug Administration -- Laws, regulations and rules, Plavix (Medication) -- Intellectual property, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Intellectual property
Abstract

Sanofi-Synthelabo, France's second-biggest drug maker, won a new patent in the United States for the heart treatment Plavix, its No. 2 medicine. The patent covers an improved form of the […]

Published
2002

16. Gaming the drug patent system

Subjects
Government regulation, Patent/copyright issue, Drugs -- Laws, regulations and rules -- Intellectual property, Patents -- Laws, regulations and rules, Pharmaceutical industry -- Intellectual property
Abstract

With high drug prices becoming an acrimonious part of the health care debate, attention has justifiably focused on the devious tactics used by some pharmaceutical companies to extend the patents […]

Published
2002

17. Brazil welcomes global move on drug patents

Author

Rich, Jennifer L.

Subjects
Government regulation, World Trade Organization -- Laws, regulations and rules -- Intellectual property, Generic drugs -- Laws, regulations and rules -- Intellectual property, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Laws, regulations and rules -- Intellectual property, Brazil -- Social policy
Abstract

The Brazilian government, which has challenged the giant drug companies' patent defenses perhaps more aggressively than any other country, hailed the World Trade Organization's declaration on drug patents as an […]

Published
2001

18. Patented Medicines (Notice Of Compliance) Listing Update

Subjects
Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Laws, regulations and rules -- Intellectual property, Government regulation, Business, international
Abstract

Listing a patent on the Patent Register maintained by the Minister of Health is the gateway through which an innovator gains access to the provisions of the Patented Medicines (Notice [...]

Published
2012

19. Pharmaceutical & Biotech Lifecycle Management (II)

Author

Bucknell, Duncan

Subjects
Patent law -- Interpretation and construction, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Intellectual property -- Laws, regulations and rules, Government regulation, Business, international
Abstract

How does timing of 1st non-innovator patent affect the period of monopoly for a new drug? This is the second in a series of articles on Pharmaceutical & Biotech Lifecycle [...]

Published
2007

20. Ireland flooded with fake Viagra.

Author

Josephberg, Kara, Lange, David M., Pollack, Jane, Victoriano, Jenna, Gitig, Oriyan, van Nes, Alexandra D., and Wagner, Scott N.

Subjects
Viagra (Medication) -- Intellectual property, Drugs -- Laws, regulations and rules -- Intellectual property, Piracy (Copyright) -- Laws, regulations and rules, Government regulation
Abstract

Pirated anti-impotence drugs advertised in an Irish newspaper and in Dublin sex shops as "Viagra Substitutes" have triggered an investigation by the Irish Medicines Board. The pills, called Camagra, reportedly [...]

Published
2003

21. Big pharma's bad week in Washington. (Drug Patents)

Author

Mullin, Rick

Subjects
Drugs -- Laws, regulations and rules -- Intellectual property, Patents -- Laws, regulations and rules, Pharmaceutical industry -- Laws, regulations and rules -- Intellectual property, Drug Price Competition and Patent Term Restoration Act of 1984, Business, Chemicals, plastics and rubber industries, Government regulation, Patent/copyright issue, Intellectual property, Laws, regulations and rules
Abstract

Brand-name drug makers suffered a stinging defeat in the Senate last week, when a bill aimed at closing loopholes in the 1984 Hatch-Waxman drug patent law passed in a 78-21 [...]

Published
2002

22. Court decision inches generic Augmentin forward. (Pharmacy Watch)

Subjects
GSK PLC -- Intellectual property -- Laws, regulations and rules, Patent law -- United States, Generic drugs -- Laws, regulations and rules -- Intellectual property, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Intellectual property, Government regulation, Business, Pharmaceuticals and cosmetics industries, Retail industry, Augmentin (Medication) -- Intellectual property
Abstract

A federal district court's ruling May 23 declared three GlaxoSmithKline's U.S. patents for the antibiotic Augmentin (amoxicillin & potassium clavulanate) invalid, further clearing the way for generic drug makers Geneva, [...]

Published
2002

23. Court questions generic Taxol marketing. (Generics Watch)

Author

Caires, Saskia De

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, American BioScience Inc. -- Intellectual property -- Laws, regulations and rules, IVAX Corp. -- Laws, regulations and rules -- Intellectual property, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmaceutical industry -- Laws, regulations and rules -- Intellectual property, Government regulation, Business, Pharmaceuticals and cosmetics industries, Retail industry, Taxol (Medication) -- Laws, regulations and rules -- Intellectual property
Abstract

The generic version of the breast cancer drug Taxol (paclitaxel) could be pulled off the market if a recent federal court ruling stands. A Nov. 6 federal appeals court ruled [...]

Published
2001

24. Biotechnology companies applaud new patent rules

Author

Hirschman, Carolyn

Subjects
Biotechnology industry -- Laws, regulations and rules -- Intellectual property, Drugs -- Laws, regulations and rules -- Intellectual property, Patents -- Laws, regulations and rules, Government regulation, Patent/copyright issue, Business, Economics, Business, regional
Abstract

Area biotechnology companies are breathing easier since the federal government made patents for drugs and therapeutics easier to get. The recent changes should help them get financing more easily and [...]

Published
1995

25. The price for more generic drugs

Author

Sun, Marjorie

Subjects
Pharmaceutical Manufacturers Association -- Intellectual property -- Political activity, Generic drugs -- Intellectual property -- Laws, regulations and rules, Drugs -- Laws, regulations and rules -- Intellectual property, Pharmacy -- Laws, regulations and rules -- Intellectual property, Science and technology, Government regulation, Political activity, Intellectual property, Laws, regulations and rules
Abstract

The Price for More Generic Drugs When the Pharmaceutical Manufacturers Association (PMA) last year asked Congress for more patant protection of drugs, Representative Henry Waxman (D-Calif.) argued that the drug [...]

Published
1984

Catalog

Books, media, physical & digital resources
See catalog results